Regis Healthcare Ltd. (REG) AI Stock Analysis

• Market Cap: AU$1.90B
• Dividend Yield: 2.57%
• Average Volume (3M): 1.55M
• Price to Earnings (P/E): 39.6
• Beta (1Y): 1.18
• Revenue Growth: 14.61%
• EPS Growth: N/A
• Country: AU
• Employees: 11,000
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 0.08
• Shares Outstanding: 301,249,360
• 10 Day Avg. Volume: 2,698,119
• 30 Day Avg. Volume: 1,553,492
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: AU$7.99
• Price Target Upside: 26.83% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 7

• Rating: 47 Neutral
• Price Target: AU$6.50 ▲(3.17% Upside)

Regis Healthcare Ltd. faces significant challenges with high financial leverage and negative equity, which are major concerns despite some operational efficiencies. The technical indicators suggest a bearish trend, and the stock appears overvalued based on its P/E ratio. These factors collectively contribute to a lower overall stock score.

Regis Healthcare Ltd. Business Overview & Revenue Model

Company Description

Regis Healthcare Limited provides residential aged care services in Australia. The company offers home care services, including personal hygiene and care, dressing and undressing, mobility and transportation, rehabilitation, and others; and home help services, such as cleaning, cooking, shopping, transportation, and facilitating social outings. It also provides companionship, and government-funded and private home care services; and owns and operates specialist retirement and independent living villages, which offers laundry, meals, and cleaning, as well as allied health services comprising physiotherapy, podiatry, diversional therapy, and therapeutic activities. In addition, the company provides aged care services, including ageing-in-place, respite care, dementia care, and palliative care services; in-home disability support and veterans' home care services; and therapeutic services to people living in the community, in retirement villages, and low care homes, as well as operates Day Respite centres. As of June 30, 2022, it owned and operated 64 residential aged care homes. The company was formerly known as Fairway Investment Holdings Pty Ltd. and changed its name to Regis Healthcare Limited in 2014. Regis Healthcare Limited was founded in 1994 and is based in Armadale, Australia.

How the Company Makes Money

Regis Healthcare Ltd. generates revenue primarily through the provision of aged care services. Key revenue streams include government funding, resident contributions, and additional services offered to residents. The company receives government subsidies and funding under Australian aged care legislation, which form a significant part of its income. Resident contributions, including daily fees and accommodation payments, also contribute to the company's earnings. Additionally, Regis offers extra services, such as specialized care programs and lifestyle activities, which provide additional revenue. The company's financial performance is influenced by factors such as occupancy rates, government policy changes, and the overall demand for aged care services.

Regis Healthcare Ltd. Financial Statement Overview

Summary

Regis Healthcare Ltd. shows signs of revenue recovery and operational efficiency, as evidenced by improved margins. However, the balance sheet reveals high leverage and negative equity, posing financial risks. Cash flow generation is robust, but declining free cash flow growth could be a concern. Overall, while there are positive trends, financial stability remains a challenge.

Income Statement

Regis Healthcare Ltd. has shown a positive revenue growth rate of 4.98% in the latest year, indicating a recovery trend. The gross profit margin has significantly improved to over 100%, suggesting effective cost management. However, the net profit margin remains low at 4.25%, reflecting challenges in converting revenue into profit. The EBIT and EBITDA margins are healthy, indicating operational efficiency.

Balance Sheet

The company has a negative stockholders' equity, resulting in an unfavorable debt-to-equity ratio. This indicates high financial leverage and potential risk. The return on equity is negative, suggesting inefficiencies in generating returns from shareholders' investments. The equity ratio is also concerning, highlighting a reliance on debt financing.

Cash Flow

Operating cash flow is strong relative to net income, indicating good cash generation from operations. However, free cash flow has declined by 9.13%, which could impact future investments. The free cash flow to net income ratio is healthy, suggesting that the company is generating sufficient cash relative to its earnings.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.16B	1.15B	1.01B	771.48M	717.89M	685.87M
Gross Profit	168.77M	141.46M	47.17M	-3.78M	5.18M	67.54M
EBITDA	240.75M	240.44M	191.45M	96.81M	55.86M	82.65M
Net Income	48.95M	48.95M	-21.41M	-28.45M	-38.80M	19.95M
Balance Sheet
Total Assets	2.11B	2.11B	1.81B	1.71B	1.76B	1.75B
Cash, Cash Equivalents and Short-Term Investments	192.47M	192.47M	64.91M	61.32M	4.15M	3.89M
Total Debt	5.11M	5.11M	3.84M	71.07M	113.32M	153.41M
Total Liabilities	2.12B	2.12B	1.84B	1.67B	1.68B	1.61B
Stockholders Equity	-16.72M	-16.72M	-22.89M	38.39M	79.01M	141.97M
Cash Flow
Free Cash Flow	219.64M	219.64M	186.57M	53.73M	67.60M	87.75M
Operating Cash Flow	306.11M	306.11M	252.30M	105.16M	114.79M	105.03M
Investing Cash Flow	-132.74M	-132.74M	-136.59M	6.58M	-48.62M	7.50M
Financing Cash Flow	-45.81M	-45.81M	-112.12M	-43.17M	-62.39M	-119.47M

Regis Healthcare Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 6.30
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:REG, the sentiment is Negative. The current price of 6.3 is below the 20-day moving average (MA) of 7.80, below the 50-day MA of 8.00, and below the 200-day MA of 7.09, indicating a bearish trend. The MACD of -0.34 indicates Positive momentum. The RSI at 28.34 is Positive, neither overbought nor oversold. The STOCH value of 5.59 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:REG.

Regis Healthcare Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ACL	70 Outperform	487.52M	14.64	―	5.02%	6.73%	37.16%
RHC	61 Neutral	7.31B	1,082.77	―	2.52%	6.82%	-99.27%
IDX	61 Neutral	1.05B	187.50	0.67%	2.31%	33.54%	―
PSQ	55 Neutral	246.46M	123.98	3.31%	3.51%	9.05%	-75.79%
BOT	53 Neutral	304.01M	-3.31	―	―	456.50%	-457.14%
REG	47 Neutral	AU$1.90B	39.63	-276.16%	2.57%	14.61%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Regis Healthcare Ltd. Corporate Events

Regis Healthcare Responds to Government’s Aged Care Pricing Changes

Regis Healthcare Limited has acknowledged the Australian Government’s recent announcement regarding increased pricing for the Australian National Aged Care Classification (AN-ACC) and hotelling supplement. These changes are aimed at funding wage increases for direct care workers and nurses as per the Fair Work Commission’s recommendations. Regis is currently assessing the financial implications of these changes and will continue to update the market in line with its disclosure obligations.

The most recent analyst rating on (AU:REG) stock is a Hold with a A$7.50 price target. To see the full list of analyst forecasts on Regis Healthcare Ltd. stock, see the AU:REG Stock Forecast page.

Regis Healthcare Director Increases Shareholding

Regis Healthcare Ltd has announced a change in the director’s interest notice, specifically regarding Sally Margaret Freeman. The director acquired 4,805 ordinary shares on the market, increasing her total holdings to 87,267 shares. This acquisition reflects a strategic move in the company’s governance, potentially impacting its market perception and stakeholder confidence.

The most recent analyst rating on (AU:REG) stock is a Buy with a A$9.00 price target. To see the full list of analyst forecasts on Regis Healthcare Ltd. stock, see the AU:REG Stock Forecast page.

Regis Healthcare Director Increases Shareholding

Regis Healthcare Ltd announced a change in the director’s interest, with Graham Kennedy Hodges acquiring 22,000 ordinary shares, increasing his total holdings to 132,000 shares. This acquisition, valued at $170,588.70, was conducted through an on-market trade, reflecting a potential vote of confidence in the company’s future prospects by its director.

The most recent analyst rating on (AU:REG) stock is a Buy with a A$9.00 price target. To see the full list of analyst forecasts on Regis Healthcare Ltd. stock, see the AU:REG Stock Forecast page.

Regis Healthcare Director Increases Stake in Company

Regis Healthcare Ltd announced a change in the director’s interest notice, with Jodie Lee Leonard acquiring 12,500 ordinary shares, increasing her indirect interest to 23,705 shares. This acquisition reflects a strategic move by the director, potentially indicating confidence in the company’s future prospects, which could have implications for stakeholders and market perception.

The most recent analyst rating on (AU:REG) stock is a Buy with a A$9.00 price target. To see the full list of analyst forecasts on Regis Healthcare Ltd. stock, see the AU:REG Stock Forecast page.

Regis Healthcare Sets Date for Annual General Meeting

Regis Healthcare Limited has announced that its Annual General Meeting will be held on November 18, 2025. The company has set September 15, 2025, as the deadline for director nominations. This meeting is a significant event for stakeholders as it provides insights into the company’s future direction and governance.

The most recent analyst rating on (AU:REG) stock is a Buy with a A$9.00 price target. To see the full list of analyst forecasts on Regis Healthcare Ltd. stock, see the AU:REG Stock Forecast page.

Regis Healthcare Ltd. Releases 2025 Corporate Governance Statement

Regis Healthcare Ltd. has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. This statement outlines the company’s adherence to the ASX Corporate Governance Council’s recommendations, highlighting their commitment to transparency and accountability in their management practices. The announcement underscores the company’s dedication to maintaining robust governance structures, which is crucial for its stakeholders and enhances its industry positioning.

The most recent analyst rating on (AU:REG) stock is a Hold with a A$8.00 price target. To see the full list of analyst forecasts on Regis Healthcare Ltd. stock, see the AU:REG Stock Forecast page.